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Abstract
Background: Complex human diseases are often caused by multiple mutations, each of which
contributes only a minor effect to the disease phenotype. To study the basis for these complex
phenotypes, we developed a network-based approach to identify coexpression modules specifically
activated in particular phenotypes. We integrated these modules, protein-protein interaction data,
Gene Ontology annotations, and our database of gene-phenotype associations derived from
literature to predict novel human gene-phenotype associations. Our systematic predictions provide
us with the opportunity to perform a global analysis of human gene pleiotropy and its underlying
regulatory mechanisms.
Results: We applied this method to 338 microarray datasets, covering 178 phenotype classes, and
identified 193,145 phenotype-specific coexpression modules. We trained random forest classifiers for
each phenotype and predicted a total of 6,558 gene-phenotype associations. We showed that 40.9%
genes are pleiotropic, highlighting that pleiotropy is more prevalent than previously expected. We
collected 77 ChIP-chip datasets studying 69 transcription factors binding over 16,000 targets under
various phenotypic conditions. Utilizing this unique data source, we confirmed that dynamic
transcriptionalregulationisanimportantforcedrivingtheformationofphenotypespecificgenemodules.
Conclusion: We created a genome-wide gene to phenotype mapping that has many potential
implications, including providing potential new drug targets and uncovering the basis for human
disease phenotypes. Our analysis of these phenotype-specific coexpression modules reveals a high
prevalence of gene pleiotropy, and suggests that phenotype-specific transcription factor binding
may contribute to phenotypic diversity. All resources from our study are made freely available on
our online Phenotype Prediction Database [1].
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A major goal of modern genetics is to determine which
genes are associated with which human phenotypes.
Over the course of the last few decades, studies
uncovering the basis for Mendelian diseases have been
extremely successful, typically identifying causal muta-
tions in single genes [2]. However, most human
phenotypes, e.g. complex diseases such as cancer or
neurological diseases, are controlled by multiple genes,
each of which has a minor contribution to the disease
phenotype [3]. Therefore, to effectively identify genes
that are related to complex phenotypes, the approach
must consider groups of genes rather than studying genes
in isolation. Numerous methods have been developed
for identifying gene modules from protein-protein
interaction (PPI) networks [4], metabolic networks [5],
or transcription-regulatory networks [6], however these
network data are often lack human phenotype-specific
information.
In this study, we identified gene modules that are
specifically coexpressed in datasets that study particular
human phenotypes. Identifying phenotype-specific
modules in human is far more difficult than in model
organisms because the phenotypes can only be observed
rather than working directly with the biological path-
ways that define them. Ideally, these biological pathways
should be reverse-engineered from data taken from
individuals that display particular phenotypes. Public
repositories of microarray data are a valuable resource
for this type of analysis because they contains hundreds
of well annotated expression datasets that span a wide
variety of phenotypic conditions. It is known that
identifying co-expression modules frequently occurring
across multiple microarray datasets significantly
enhances the signal to noise ratio [7-9]. Here, we
identified co-expression modules that are present recur-
rently and specifically in datasets of one phenotype by
using the remaining datasets as a background.
Using these phenotype-specific coexpression modules,
we performed a systematic prediction of gene-phenotype
associations by integrating three data sources: previously
known associations derived from literature text mining,
Gene Ontology annotations, and protein-protein inter-
actions. A previous study designed an approach to
identify gene modules in human PPI networks and
used them to predict novel gene-phenotype associations
[10]. Our approach differs from this in that it integrates
hundreds of microarray datasets in parallel to identify
modules, and then superimposes protein-protein inter-
actions as well as phenotype and functional annotations
to make predictions.
The systematic annotation of gene-phenotype associa-
tions provides us with the opportunity to perform the
first global analysis of gene pleiotropy in human. Gene
pleiotropy has the potential to explain the vast human
phenotypic diversity, considering that the number of
human genes is far fewer than originally anticipated
[11]. Several large scale studies of pleiotropy have been
performed on model organisms such as yeast [12,13]
and C. elegans [14]. In humans however, pleiotropy is
often only recognized following the in-depth analysis of
a single gene or gene family [15-17]. To our knowledge,
no comprehensive determination or prediction of which
genes exhibit pleiotropic behavior throughout the entire
human genome has been previously performed. Based
on our modular approach, we have defined a novel
concept, modular pleiotropy, as the pleiotropic behavior of
genes resulting from their presence in their modules, as
we have shown that changes in module membership can
define a gene’s pleiotropic behavior. To further under-
stand the underlying mechanisms of phenotypic diver-
sity, we utilized the rapid accumulation of ChIP-chip
datasets, measured under various phenotypic conditions,
and tested whether the phenotype specificity of our
modules, as well as specific instances pleiotropy, could
be attributed to dynamic phenotype-specific gene
regulation.
By integrating 338 human microarray datasets represent-
ing 283 phenotypes, we have identified 193,145
phenotype-specific modules. We subsequently predicted
6,558 novel gene-phenotype associations covering 3,183
genes, and showed that 40.9% of genes are associated
with multiple phenotypes, and can thus be considered
pleiotropic. We collected 77 Chip-chip datasets, anno-
tated them with matching phenotypes, and confirmed
that dynamic transcriptional regulation is an important
force driving the formation of phenotype-specific mod-
ules. Our module-based approach has the advantage of
not only predicting pleiotropy, but also suggesting how a
gene is pleiotropic, exerting different phenotypic func-
tions in different transcriptional and regulatory contexts.
We have provided all the data from our study, including
the gene phenotype database we constructed via text
mining, our phenotype-specific modules, and our novel
phenotype predictions, in our online Phenotype Predic-
tion Database [1].
Results and discussion
Systematic annotation of gene-phenotype association
Our approach identified phenotype-specific modules
preferentially coexpressed in microarray datasets that
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to perform systematic phenotype prediction, study gene
pleitropy, and integrated phenotype-specific transcrip-
tion factor binding data to build dynamic regulatory
networks (Figure 1). We collected 338 human micro-
array datasets from the NCBI Gene Expression Omnibus
(GEO) [18]. By mapping the dataset annotations onto
UMLS [19] phenotype terms we obtained 283 phenotype
classes each of which contained at least 3 microarray
datasets. For the purposes of this paper, we employ a
broad interpretation of the term phenotype, which
includes diseases, tissues, and cell types.
We previously designed a Multiple Objective Simulated
Annealing (MOSA) algorithm that robustly identifies
groups of genes that are preferentially coexpressed in
datasets of a specific phenotype class [20]. The simulated
annealing procedure was designed to optimize four
characteristics of phenotype-specific coexpression mod-
ules: size, density, specificity for the phenotype datasets,
and a summary statistic of module density which we
term density differential. The goal of this approach was
to identify genes modules that exhibit a coexpression
signature which is specific to the phenotype in which
they were identified, and therefore are likely to represent
processes inherent to the phenotype.
Applying this approach, we identified 193,145 pheno-
type-specific coexpression modules that met our criteria
of a minimum size of 7, minimum density of 0.66, and a
minimum phenotypic enrichment p-value of less than
0.01 after FDR correction. These modules spanned 178
phenotypes and had an average size of 13.7. A more
detailed description of this algorithm is outlined in the
methods section.
In this study, starting with the phenotype-specific
modules, we predicted gene phenotype associations by
additionally incorporating the following three data
sources: our database of gene-phenotype associations
obtained from text-mining of the Gene Reference Into
Function (GeneRIF) resource, the Gene Ontology data-
base, and protein-protein interaction data (details in
methods).
We trained a different random forest classifier for the 52
phenotypes for which the phenotype-specific coexpres-
sion modules contained genes with GeneRIF entries with
the same phenotype. Each classifier therefore depended
on the the set of genes that were known to be associated
with the training phenotype via GeneRIF text mining, to
which we refer to as Gp. Our model contained 5 predictor
variables, and contained one observation for each gene
in the phenotype-specific modules. If a gene appeared in
more than one module, the predictor variables were
averaged across the modules.
Given a previously unannotated gene gi,w h i c hi sa
member of module mpj (the j
th module specific to
phenotype p), we predicted whether gi is associated with
phenotype p by considering the following predictive
features: i) the enrichment of the members of mpj for
genes in Gp; ii) the degree of GO annotation similarity
between gi and mpj ∩ Gp; iii) and the number of protein-
protein interactions between gi and mpj ∩ Gp.T h ef i r s t
predictor variable was the negative log p-value of the
hypergeometric test for enrichment of genes in the
module for genes in Gp. The second predictor variable
was derived from protein-protein interaction (PPI) data.
The PPI score was calculated by summing the total
number of protein-protein interactions between the
current gene and genes from Gp i nt h es a m em o d u l e .
The remaining three predictor variables were derived
from the three subtrees of GO (biological process,
cellular component, and molecular function) as follows.
For a pair of genes in the same module, the GO score for
a subtree was calculated by first identifying all GO terms
shared between the two genes. Once this set of distinct
matching terms was established, the GO score was
calculated by summing up the negative log p-values of
the significance of matches to genes in Gp.
These classifiers trained on the predictive features
discussed above predicted 6,558 gene-phenotype asso-
ciations covering 3,183 genes. For a cumulative recall
(including all phenotypes) of at least 20%, the precision
of our predictions was approximately 65%. As the
stringency of the cutoff parameter increases the precision
continues to climb above 80%. This indicates that if we
restrict the classifiers to a small number of predictions
they become extremely accurate, which would be an
ideal set to pursue in a clinical setting. The precision-
recall plot, which differs from a ROC plot by only
plotting statistics related to positive predictions, for three
classifiers compared to randomly generated modules is
shown in Figure 2. Each of our predictions is scored
based on the fraction of classification trees from the
random forest that voted for the prediction. Table 1
shows the predictions with the best scores for the 10
highest scoring predictions, stratified by phenotype,
along with supporting evidence from published papers
and Gene Ontology. GeneRIF does not contain all
published papers that discuss a gene’s association with
a phenotype, so the published papers listed in this table
represent information not used by the classifier. The first
prediction is ADRB3 for the phenotype “Urologic
BMC Bioinformatics 2010, 11(Suppl 1):S62 http://www.biomedcentral.com/1471-2105/11/S1/S62
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A flow chart of our approach pipeline for each phenotype. We designed a multiple objective simulated annealing
(MOSA) algorithm to identify phenotype-specific coexpression modules in microarray datasets. We incorporated additional
data sources into a random forest classifier to make novel gene-phenotype predictions. These modules and predictions were
used to study human pleiotropy and phenotype-specific transcription regulation.
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urologic diseases is supported by its presence in the
human urinary bladder urothelium, as well as its
regulation of urinary function [21]. Five of the predic-
tions in this table are for phenotypes related to the
immune system, such as “Phagocytes,”“ Inflammation,”
“Lymphocyte,”“ monocyte,” and “Bone Marrow Cells.”
Many of these predictions are supported by both
literature and their GO annotations which include
myeloid cell differentiation, inflammatory response,
and immune response. Two other interesting predictions
a r et h ec h e m o k i n eg e n e sC X C L 1 1a n dC X C L 2f o rt h e
phenotypes “Bone Marrow Cells” and “Inflammation”
respectively. Chemokines are master controllers of the
migration of leukocytes, which originate in bone marrow
and directly effect many functions related to the immune
system including inflammation. The remaining predic-
tions shown in the table are related to cancer and
epithelial tissue related phenotypes.
To provide a more comprehensive analysis of our
predictions, rather than just highlighting the highest
scoring predictions, we performed functional enrich-
ment analysis on each predicted set of associated genes
for each phenotype. This analysis revealed that the
majority of phenotype enriched biological processes are
consistent with the functionality of the phenotype,
which supports the quality of our predictions. For
example, in the phenotype “Squamous cell carcinoma,”
our predicted genes are enriched for GO annotations
related to skin cancer such as DNA replication, keratini-
zation, and epidermis development. GO annotations are
Figure 2
Random forest performance. Precision-recall plot depicting the training performance of the random forest classifiers for
three phenotypes.
Table 1: Highest confidence gene-phenotype association predictions stratified by phenotype
Phenotype Cutoff Gene Gene Description PMID Relevant GO Term
Urologic Diseases 1.00 ADRB3 adrenergic, beta-3-, receptor 18311486
Phagocytes 1.00 PML promyelocytic leukemia myeloid cell differentiation
Genital Neoplasms, Female 1.00 EXO1 exonuclease 1 15328369 DNA repair
Inflammation 1.00 CXCL2 chemokine (C-X-C motif) ligand 2 12892904 inflammatory response
skin disorder 0.99 SC4MOL sterol-C4-methyl oxidase-like
Lymphocyte 0.99 FPRL1 formyl peptide receptor 2 15625007 G-protein coupled receptor protein
signaling pathway
monocyte 0.99 TAP2 transporter 2, ATP-binding cassette,
sub-family B (MDR/TAP)
12234057 immune response
Bone Marrow Cells 0.99 CXCL11 chemokine (C-X-C motif) ligand 11 15102366 immune response
Epithelium 0.98 ITGB4 integrin, beta 4 15194479 cell adhesion
Neoplasms 0.98 HMHA1 histocompatibility (minor) HA-1 14502255 intracellular signaling cascade
Each phenotype is listed with the predicted gene, the gene's description, and the proportion of decision trees from the random forest classifier that
predicted its association to the phenotype. The final two columns provide supporting evidence in the form of a PubMed ID for a published work or a
Gene Ontology annotation that is consistent with the phenotype.
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phenotype “Brain” is enriched for synaptic transmission
and monovalent inorganic cation transport. We high-
light additional examples of significantly (FDR p-value <
0.01) overrepresented GO terms within predicted gene
sets for phenotypes in Table 2.
T h ep r e v a l e n c eo fg e n ep l e i o t r o p y
Our large-scale gene-phenotype association prediction
provided us with a unique opportunity to systematically
study gene pleiotropy. The simplest definition of
pleiotropy, a gene being annotated with multiple
UMLS phenotype terms, is inadequate here. For example,
TAL1 is annotated with both “leukemia” and “Immuno-
proliferative Disorders,” but these do not constitute two
distinct phenotype associations because one is simply a
more general phenotype than the other. Other groups
have employed phenotype distance metrics and declared
two phenotypes different when their distance exceeded a
certain threshold [10,22]. However, this type of method
relies on the selection of an arbitrary threshold, which
can significantly affect the results. Here, we defined
pleiotropy using the structure of the parental links
within the UMLS phenotype ontology. We considered a
gene pleiotropic if it was annotated with at least two
phenotypes, neither of which is a descendant of the
other.
Applying this definition of pleiotropy to only the disease
phenotypes revealed that 40.9% of the 8,504 genes in
our study are associated with at least one pair of distinct
phenotypes. It should be noted that this percentage is
likely to be an over estimate of pleiotropic genes, since
UMLS text mining of GeneRIF terms can lead to incorrect
annotations and therefore pleiotropy. The addition of
our phenotype predictions resulted in 607 novel
pleiotropic genes. Furthermore, 725 genes that were
previously pleiotropic were annotated with a new
phenotype distinct from all previous annotations,
resulting in a new case of pleiotropy.
Pleiotropy can be determined and observed in a variety
of ways. In this study, we predicted whether a particular
gene exhibits pleiotropic behavior based upon its
membership in phenotype-specific coexpression mod-
ules. We therefore term this type of pleiotropy modular
pleiotropy,i nw h i c hag e n e ’s pleiotropic behavior is
determined by module membership. An example that
illustrates this phenomenon is depicted in Figure 3
involving two modules, one specific to “nervous system
disorders” and the other to “Neoplasms, Glandular and
Epithelial.” These modules share six genes related to the
extracellular matrix, the substrate upon which cells
migrate, proliferate, and differentiate. It is not surprising
to find these genes associated with epithelial cancer, as
many studies have shown that the extracellular matrix is
heavily involved in tumor progression and metastasis
[23,24]. The extracellular matrix also plays a major role
in the development and repair of the central nervous
system, supporting its presence in both modules [25]. In
each of the two overlapping modules, the remaining,
unshared genes also include genes from the extracellular
matrix and additional genes that are highly specific to
the phenotypes in which the modules were discovered.
These include the well known Alzheimer’s susceptibility
locus APOE, an actin gene differentially expressed in
schizophrenia patients (ACTG1), a brain-specific tubulin
Table 2: Overrepresented GO terms in predicted genes. Seven of the UMLS phenotypes are highlighted, along with the number of
phenotype-specific coexpression modules and number of novel predicted associated genes. The final column contains a subset of the
overrepresented GO biological processes in the predicted genes that are consistent with the phenotype. The full table is available on
our supplementary website
Phenotype Modules Predictions Over-represented GO annotations
Adenocarcinoma 2367 69 cell cycle process (3.5e-06)
DNA replication (4.1e-06)
cell cycle phase (8.5e-06)
Bone Marrow Cells 5390 421 immune response (3.8e-06)
immune system process (7.2e-06)
response to virus (2.0e-05)
Brain 8373 329 synaptic transmission (3.8e-06)
monovalent inorganic cation transport (1.7e-05)
Connective and Soft Tissue Neoplasm 1463 22 cell cycle process (4.3e-14)
cytoskeleton-dependent intracellular transport (8.6e-07)
Musculoskeletal Diseases 5421 324 actin filament-based process (8.2e-06)
Squamous cell carcinoma 1268 54 DNA replication (2.5e-08)
keratinization (8.1e-05)
epidermis development (1.0e-04)
nervous system disorder 8235 628 respiratory electron transport chain (5.1e-07)
acetyl-CoA catabolic process (3.2e-05)
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tubulin polymerizer that serves as a neuroprotectant
(S100A4). The neoplasms module also contains genes
related to the extracellular matrix, and genes with known
roles in neoplastic processes such as tumor progression,
tumor necrosis induction, tumor suppression, and
tumor invasion [26,27].
We would also like to highlight an interesting prediction
of pleiotropy for the gene BGN, which is present in both
modules. This prediction issupportedby the RefSeqentry
for this gene, which states that it is thought to transfer
growth factors between cells and that it may promote
neuronal survival. Some additional evidence for BGN’s
activity in cancer was discovered by a study that showed
BGN controls cell growth in pancreatic cancer cells [28].
Studies have demonstrated BGN’s potential role in the
human nervous system as well, as BGN is overexpressed
inrats afterbraininjuryand it sustainedthe survivalofrat
neocortical neurons in culture [29,30].
The above example nicely illustrates the power of our
classification method to make reliable phenotype pre-
dictions, and in particular to identify pleiotropy and its
modular context.
Phenotype-specific transcriptional regulation
We hypothesized that regulatory networks are not static
relationships between transcription factors and their
target genes, but rather dynamic networks that vary to
dictate different observed phenotypes, such as tissue
types and diseases. Thanks to the accumulation of ChIP-
chip experiments, each of which provides genome-wide
T Fb i n d i n gd a t ad e r i v e du n d e rp a r t i c u l a rp h e n o t y p i c
c o n d i t i o n s ,w ew e r ea b l et ot e s tt h i sh y p o t h e s i sb y
determining whether TF binding detected under a
phenotypic condition preferentially occurs in genes
belonging to modules specific to the same phenotype.
This concordance between or phenotype-specific coex-
pression modules and phenotype-specific binding from
ChIP-chip data also serves to independently validate the
phenotype-specificity of our modules.
We compiled 77 ChIP-chip datasets from the public
repositories and also manually collected results from
literature publications. These data include 69 TFs and
16,122 target genes, which can be found on our online
Phenotype Prediction Database [1]. Applying our text
mining procedure to these datasets resulted in a total of
208 phenotypes including diseases, tissues and cell
types. Of these 208 phenotypes, we focused on the 97
Figure 3
An example of modular pleiotropy with a pleiotropic component related to the extracellular matrix.T h e
modules shown are specific to microarray datasets that study “nervous system disorders,” and “Neoplasms, Glandular and
Epithelial.” The shaded elliptical nodes represent genes associated with the module phenotype (via GeneRIF text mining),
whereas the shaded diamond nodes represent predictions made by our random forest classifier. The edge opacity indicates
how often a pair of genes was coexpressed in the microarray datasets for which the module was coexpressed.
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datasets we had collected. This provided us with one of
the most comprehensive collections of regulatory data
available, with the phenotypic conditions that each
dataset studied.
For each phenotype-specific module, we tested the
member genes for enrichment of TF binding derived
from ChIP-chip datasets that study related phenotypes.
Out of the 97 ChIP-chip phenotypes, 43 exhibited a
statistically significant preferential binding (Mann-Whit-
ney test, FDR < 0.05), indicating that target genes from
ChIP-chip data are more likely to form coexpression
modules in microarray datasets whose phenotype anno-
tations match those of the ChIP-chip experiment. The full
table of p-values resulting from this analysis are available
online on our Phenotype Prediction Database [1].
One example of a phenotype that exhibits preferential
ChIP-chip binding is “Prostatic Neoplasms,” which is
studied by a single ChIP-chip dataset profiling androgen
receptor binding. The phenotype-specific preferential
binding is shown in Figure 4. The proportion of
phenotype-specific modules for this phenotype that are
significantly enriched for androgen receptor binding
(hypergeometric p- v a l u e<0 . 0 2 5 )i so v e r1 6t i m e sh i g h e r
than the modules specific to other phenotypes. This
strong over representation of significant binding enrich-
ment for our modules demonstrates the ability of our
method to detect evidence of phenotype-specific TF
binding, despite being provided only a small fraction of
the complete transcriptional regulatory information
r e l a t e dt ot h i sp h e n o t y p e .
The second example in the figure is the more general
phenotype “Malignant Neoplasms”. The distribution of
TF binding enrichment is more continuous for this
example due to the larger number of related phenotype-
specific modules and ChIP-chip datasets. As with the
previous example, there is a higher relative frequency of
significantly bound modules specific to phenotypes that
match the phenotype of the TF binding. Also, the
frequency of the most significant binding enrichment
(hypergeometric p-value < 0.025) within the distribution
of the related phenotype-specific modules is more than
twice as high as the frequency of all other enrichment p-
values. This can be attributed to the much higher
quantity of ChIP-chip data available for this phenotype,
which allowed for more significant binding for our
transcription modules. This result implies that as more
ChIP-chip data becomes available, we would expect to
see the significance of binding enrichment of our
Figure 4
Distribution of ChIP-chip TF binding enrichment p-values for phenotype-specific coexpression modules.T h e
distributions of ChIP-chip TF-binding enrichment p-values are shown for two ChIP-chip phenotypes: Prostatic Neoplasms and
Malignant Neoplasms. The first and second rows of distributions correspond to those derived from microarray datasets with a
phenotype related to the ChIP-chip data phenotype and those derived from unrelated phenotypes respectively. The final row
displays the log2 ratio of the two distributions relative to their respective total sizes.
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Although the complete set of phenotype-specific binding
is not available, we were still able to construct portions
of these dynamic transcriptional networks by combining
phenotype-specific coexpression modules with TF bind-
ing from the same phenotypes. For example, Figure 5
shows two overlapping modules, each specific to
different phenotypes, and each significantly enriched
for phenotype-specific binding that matches its pheno-
type. The two modules are each preferentially coex-
pressed in datasets studying a specific phenotype: one
“Squamous Cell Neoplasms” and the other “Immuno-
proliferative Disorders."
As with the previous example of pleiotropy, these two
modules are phenotype specific and are enriched with
genes related to each phenotype. The “Squamous Cell
Neoplasms” module contains ten genes, five of which
were previously annotated with the phenotype, and is
also significantly enriched for GO terms consistent with
cancer of squamous tissue: keratinocyte differentiation
(p-value 2.8e-9) and epidermis development (p-value
5.1e-7). The seven gene “Immunoproliferative Disor-
ders” module contains four genes that were annotated
with the phenotype, as well as being enriched for GO
annotations related to the immune system such as
leukocyte chemotaxis (p-value 5.1e-7) and defense
response (p-value 5.0e-6). The modules share two pro-
inflammatory calcium binding genes, S100A9 and
S100A12, that are implicated together in a number of
diseases [31]. S100A9 was previously annotated with
both phenotypes, making it an example of a pleiotropic
gene confirmed by its presence in two coexpression
modules.
Our analysis of phenotypic conditions of the ChIP-chip
data revealed that each of these modules were signifi-
cantly enriched for phenotype-specific TF binding. The
Figure 5
An example of modular pleiotropy with phenotype-specific regulatory data. The genes in the module on the left are
specifically coexpressed in “Squamous Cell Neoplasms” microarray datasets, while those on the right are specifically
coexpressed in “Immunoproliferative Disorders” microarray datasets. Two phenotype-specific modules containing genes with
GeneRIF entries for the same phenotype (shaded). The edge opacity indicates how often a pair of genes was coexpressed in
the microarray datasets for which the module was coexpressed. The opacity the edges indicates the degree of coexpression.
The transcription factor binding, derived from ChIP-chip datasets that studied phenotypes related to the microarray datasets,
is shown with dotted arrows.
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was derived from 18 ChIP-chip datasets that study the
related phenotype “Epithelial Cells.” The module is
significantly enriched for the USF1 transcription factor
(p-value 0.02) which binds SERPINB3 and SERPINB4 in
epithelial cells, as well as marginally enriched for CREB
(p-value 0.06) which binds IVL and S100A9.
The binding for the ‘Immunoproliferative Disorders”
module was derived from datasets that study “Myeloid
Cells,” which was studied by 16 datasets. The majority of
the binding was by the transcription factor NF-kB, which
in myeloid cells binds three genes (p-value 0.0006) and
is known to play a role in regulation of the immune
system as well as types of cancer [32]. This included both
shared genes (S100A9, S100A12), and a gene that
performs cytoprotective and anti-apoptotic roles in
neutrophils (BCL2A1) [33]. This concordance between
microarray expression data and regulatory ChIP-chip
data demonstrates that our approach of finding pheno-
type-specific transcription modules can not only identify
gene-phenotype relationships, but that it can be com-
bined with TF binding data to further explain the
molecular mechanisms and regulatory pathways under-
lying phenotypes and pleiotropy.
Conclusion
We have developed a method to determine the pheno-
typic effects of particular genes in humans, where
phenotype prediction is far more difficult than in model
organisms. This difficulty is largely due to our inability to
study the underlying biological pathways directly, for
example by inducing mutations or otherwise perturbing
phenotype-related pathways. Our approach circumvents
this limitation because the identified gene modules are
preferentially active in datasets that study a particular
phenotype, and thus are likely to represent phenotype-
specific pathways. Using public resources that provide
phenotype data, such as UMLS and GeneRIF, we made
novel predictions that we believe will be useful in a
clinical setting, further our understanding of disease
pathways, and serve as potential drug targets.
In addition, we propose that regulatory networks should
be viewed as dynamic networks with topology depen-
dent upon the phenotypic conditions that they model.
Since ChIP-chip experiments examine binding data
under specific phenotypic conditions, their data provide
a static snapshot of this dynamic regulatory network.
Our results support this hypothesis by demonstrating
preferential binding of transcription factors to coexpres-
sion modules in similar phenotypes.
Our pleiotropy analysis, complemented by our pheno-
type predictions, indicates that pleiotropy in humans
may be a more widespread phenomenon than previously
thought. Further study of how coexpression partners
change in different tissues and the role phenotype-
specific transcriptional regulation plays in shaping
these changes will provide deeper insight into the
underlying cause of phenotypic diversity as well as
genetic pleiotropy.
Methods
Data sources
The microarray datasets were downloaded from NCBI
GEO, and were from Affymetrix human platforms U95,
U133, U133A 2.0, and U133 Plus 2.0. All datasets from
these platforms with at least eight experimental samples
were included, for a total of 338 datasets, which are
i n c l u d e di nt h eo n l i n eP h e n o t y p eD a t a b a s e[ 1 ] .W eo n l y
included the 8,504 genes that were present in all datasets
and had at least one probe that mapped uniquely to it.
We annotated each of the datasets with phenotype terms
by mining the titles and MeSH terms of the associated
papers with the UMLS MMTx tool, following the
approach by Butte and Kohane [34].
Creation of a database of GeneRIF gene-phenotype
associations
To objectively assign individual genes to the phenotypes
with which they are known to be associated, we used the
UMLS MetaMap Transfer tool to identify phenotypic
terms from the UMLS Metathesaurus that were present in
the raw text for each gene within Gene Reference Into
Function (GeneRIF). GeneRIF submissions often contain
concise information about the function of the gene, or
whether it is known to be associated with any disease
phenotypes. Therefore, by applying the UMLS MetaMap
Transfer tool, we created a database of gene-phenotype
associations derived from literature sources. Each asso-
c i a t i o ni nt h ed a t a b a s ew a st r a c e db a c kt ot h er o o to ft h e
tree defined by the parental phenotypes described in the
next section.
Phenotype relationships
For the Phenotype-Prediction and ChIP-chip analysis we
defined a set of related phenotypes for each phenotype
using the relationships provided by the UMLS Metathe-
saurus. The related phenotypes were defined by immedi-
ate neighbors using the set of relationships {RB, RL, RN,
RO, RQ, RU, SY}. The relationships used represent
different types of similarity as well as whether two
phenotypes are simply synonymous. The parental phe-
notypes were defined using the “PAR” relationships from
the UMLS Metathesaurus. For a given phenotype, all
phenotypes present in the trace to the root of the UMLS
graph defined by these “PAR” edges were considered
parental phenotypes.
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Our procedure is explained in detail in our previous
paper [20]. For completeness, we present an overview
here. The goal of the algorithm we used is to find sets of
genes that are significantly coexpressed specifically in
datasets related to particular phenotypes. For each of the
338 datasets in our study, we constructed an unweighted
coexpression network composed of the top 150,000
correlated genes. We designed a multi-objective simu-
lated annealing algorithm, with four objective functions
designed to maximize the size, absolute density, relative
density (to non-phenotype datasets), and specificity of
the coexpression module for the phenotype datasets. The
purpose of the relative density, or density differential,
was to reward subtle changes in module density that
would not be detected by the phenotype-specificity
objective function. The objective functions we designed
are outlined below.
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where
GP is the set of datasets annotated with the current
phenotype,
GA is the set of datasets in which the gene cluster is
dense,
and Y ~ hypergeometric (|| , || , || GGG APP
c ).
After completion of the simulated annealing procedure,
we performed post filtering to remove low-quality
modules. Our filtering criteria for each module was a
minimum size of 7, minimum density of 0.66, and a
minimum phenotypic enrichment p-value of less than
0.01 after FDR correction. These modules formed the
basis for the phenotype prediction presented in this
paper.
Random forest training
The random forest classifier was trained using 500 trees
and a maximum terminal node size of 10. The cross-
validation statistics reported were calculated using the
Out Of Bag (OOB) errors provided by the training
process. For each classifier, the positive training set was
composed of all genes that contained a GeneRIF entry
that mentioned the training phenotype. The negative set
is more difficult to define, since genes that are actually
associated with a particular phenotype may not be
labeled as such due to imperfect text processing or
missing GeneRIF annotations. Therefore, to minimize
the error of our classifier we used the phenotype
relationships defined by the UMLS to define our negative
training set. We only included genes in the negative set
that contained GeneRIF entries that were neither related
nor parental to the training phenotype (see Section
Phenotype relationships for more detail). The remaining
genes, which included the related and parental genes, and
those with no GeneRIF entries, were excluded from the
training procedure and were used for prediction after the
training of each phenotype classifier. The final predic-
tions reported for each phenotype were the positive
predicted genes from our training, as well as all
positively predicted genes from our prediction set.
ChIP-chip phenotype specificity
The phenotypes studied by each ChIP-chip dataset was
determined by performed text mining on the datasets’
title, description, MeSH headings, and associated pub-
lications’ title and abstract using the UMLS MMTx text
mining tools. Given a single phenotype present in both
ChIP-chip data and microarray data, we defined two sets
of coexpression clusters: one derived from phenotypes
related to the current phenotype, and the remaining
modules unrelated to the current phenotype. We
performed a Mann-Whitney test on the hypergeometric
test p-values for TF enrichment in modules from related
phenotypes versus the rest of the modules, to determine
whether transcription factors from the phenotype ChIP-
chip experiments exhibited significant preferential bind-
ing.
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